• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN AND SHURTLEFF, INC EMBOLIC AGENT; TISSUE ADHESIVE FOR USE IN EMBOLIZATION OF BRAIN ARTERIOVENOUS MALFORMATIONS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN AND SHURTLEFF, INC EMBOLIC AGENT; TISSUE ADHESIVE FOR USE IN EMBOLIZATION OF BRAIN ARTERIOVENOUS MALFORMATIONS Back to Search Results
Catalog Number UNK EMBOLIC AGENT
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Code Available (3191)
Event Date 09/16/2019
Event Type  Injury  
Manufacturer Narrative
Product complaint # (b)(4).Surgical intervention.Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.- attachment:(b)(4).
 
Event Description
This complaint is from a literature source.As reported in the literature publication entitled, ¿intranodal glue embolization for the management of postsurgical groin lymphocele and lymphorrhea¿ 2 patients with groin lymphatic leaks who underwent intranodal lymphatic embolization which was performed by intranodal injection with dilute n-butyl cyanoacrylate (nbca) failed embolization.The patients were handled by successful laparoscopic unroofing at 2 months and lymphatic ligation.This report describes intranodal lymphatic embolization for treatment of groin lymphatic leaks following surgery or percutaneous vascular interventions.Imaging and medical records of 10 consecutive patients (6 men; median age 66 y) who presented with groin lymphatic leaks and underwent intranodal lymphangiography and embolization between 2015 and 2017 were reviewed.Groin lymphatic leaks were defined as presence of a lymphocele with draining catheter or groin lymphorrhea manifesting as weeping of fluid from the access point and/or wound.Nbca liquid embolic agent trufill was used in this study.No device specific information (including catalog and lot number) was provided in the article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOLIC AGENT
Type of Device
TISSUE ADHESIVE FOR USE IN EMBOLIZATION OF BRAIN ARTERIOVENOUS MALFORMATIONS
Manufacturer (Section D)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
Manufacturer (Section G)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key9168383
MDR Text Key170179486
Report Number1226348-2019-00997
Device Sequence Number1
Product Code KGG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
UNK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 09/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK EMBOLIC AGENT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/16/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age86 YR
-
-